Literature DB >> 25747697

Culture and characterisation of canine mitral valve interstitial and endothelial cells.

M-M Liu1, T C Flanagan2, C-C Lu1, A T French3, D J Argyle1, B M Corcoran4.   

Abstract

Valve interstitial cells (VICs) have an important role in the aetiopathogenesis of myxomatous mitral valve disease (MMVD) in the dog. Furthermore, there is evidence that valve endothelial cells (VECs) also contribute to disease development. In addition to examining native valve tissue to understand MMVD, another strategy is to separately examine VIC and VEC biology under in vitro culture conditions. The aim of this study was to isolate and characterise canine mitral VICs and VECs from normal dog valves using a combination of morphology, immunohistochemistry and reverse transcription PCR (RT-PCR). Canine mitral VECs and VICs were isolated and cultured in vitro. The two cell populations exhibited different morphologies and growth patterns. VECs, but not VICs, expressed the endothelial markers, platelet endothelial cell adhesion molecule (PECAM-1 or CD31) and acetylated low density lipoprotein (Dil-Ac-LDL). Both VECs and VICs expressed vimentin and embryonic non-smooth muscle myosin heavy chain (SMemb), an activated mesenchymal cell marker. The myofibroblast marker, alpha smooth muscle actin (α-SMA), was detected at the mRNA level in both VEC and VIC cultures, but only at the protein level in VIC cultures. The morphological heterogeneity and expression of non-endothelial phenotypic markers in VEC cultures suggested that a mixture of cell types was present, which might be due to cell contamination and/or endothelial-mesenchymal transition (EndoMT). The use of a specific endothelial culture medium for primary VEC cultures enhanced the endothelial properties of the cells and reduced α-SMA and SMemb expression.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Canine; Cell culture; Myxomatous mitral valve disease; Valve endothelial cell; Valve interstitial cell

Mesh:

Substances:

Year:  2015        PMID: 25747697     DOI: 10.1016/j.tvjl.2015.01.011

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  7 in total

Review 1.  Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.

Authors:  Mark A Oyama; Chad Elliott; Kerry A Loughran; Alexander P Kossar; Estibaliz Castillero; Robert J Levy; Giovanni Ferrari
Journal:  Cardiovasc Pathol       Date:  2020-01-07       Impact factor: 2.185

2.  Isolation and Culture of Primary Endothelial Cells from Canine Arteries and Veins.

Authors:  Loes A Oosterhoff; Hedwig S Kruitwagen; Bart Spee; Frank G van Steenbeek
Journal:  J Vis Exp       Date:  2016-11-18       Impact factor: 1.355

3.  The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration.

Authors:  Qiyu Tang; Andrew J McNair; Kanchan Phadwal; Vicky E Macrae; Brendan M Corcoran
Journal:  Front Cardiovasc Med       Date:  2022-05-17

4.  Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.

Authors:  Karen Tan; Greg Markby; Rhona Muirhead; Rachel Blake; Lisa Bergeron; Greg Fici; Kim Summers; Vicky Macrae; Brendan Corcoran
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

5.  TGFβ2 and TGFβ3 mediate appropriate context-dependent phenotype of rat valvular interstitial cells.

Authors:  Faye Wang; Cindy Zhang; Jae Kwagh; Brian Strassle; Jinqing Li; Minxue Huang; Yunling Song; Brenda Lehman; Richard Westhouse; Kamalavenkatesh Palanisamy; Vinay K Holenarsipur; Robert Borzilleri; Karen Augustine-Rauch
Journal:  iScience       Date:  2021-02-03

6.  Mechanism of Endoplasmic Reticulum Stress Pathway in the Osteogenic Phenotypic Transformation of Aortic Valve Interstitial Cells.

Authors:  Yiming Tao; Yimin Geng; Wenpei Dang; Xinxin Xu; Hui Zhao; Lijuan Zou; Yongsheng Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-08       Impact factor: 5.555

7.  Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel.

Authors:  G R Markby; V E Macrae; B M Corcoran; K M Summers
Journal:  BMC Vet Res       Date:  2020-09-23       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.